Clinical Trial Update: Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating prophylactic Curosurf in combination with early nasal CPAP for newborn respiratory distress syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome Newborn

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Respiratory Distress Syndrome, Newborn | Phase 4 | Status: COMPLETED